doi: 10.1016/0042-6822(80)90086-0.
Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV
- PMID: 6245504
- DOI: 10.1016/0042-6822(80)90086-0
Item in Clipboard
Phosphonoformate inhibits synthesis of Epstein-Barr virus (EBV) capsid antigen and transformation of human cord blood lymphocytes by EBV
Virology.
.
No abstract available
Similar articles
-
Esters of phosphonopropionic and phosphonoacetic acids: effect on synthesis of Epstein-Barr virus (EBV) antigens and on transformation of cord blood lymphocytes by EBV.Cancer Biochem Biophys. 1980;4(3):137-43. Cancer Biochem Biophys. 1980. PMID: 6254633
-
Phosphonoacetic acid: inhibition of transformation of human cord blood lymphocytes by Epstein-Barr virus.Cancer Biochem Biophys. 1979;3(4):157-62. Cancer Biochem Biophys. 1979. PMID: 233303
-
Sensitivity of the transforming and replicative functions of Epstein--Barr virus to inhibition by phosphonoacetate.J Gen Virol. 1978 Aug;40(2):409-20. doi: 10.1099/0022-1317-40-2-409. J Gen Virol. 1978. PMID: 211188
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1989;40(2):213-85. doi: 10.1016/0163-7258(89)90097-1. Pharmacol Ther. 1989. PMID: 2543994 Review.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
Cited by
-
Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.Mol Cell Biochem. 1982 Mar 19;43(2):97-103. doi: 10.1007/BF00423097. Mol Cell Biochem. 1982. PMID: 6178013